Quantcast

Md. biopharm Rexahn likely to get patent for cancer treatment

Rexahn Pharmaceuticals Inc. received a notice from the U.S. Patent and Trademark Office that it intends to issue a patent for a cancer treatment.

To purchase a reprint of this article, contact reprints@thedailyrecord.com.